Literature DB >> 3064278

Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen.

I Olafsson1, H Löfberg, M Abrahamson, A Grubb.   

Abstract

Murine monoclonal antibodies against the major cysteine proteinase inhibitors of human biological fluids, cystatin C and kininogen, were produced. The cystatin C antibody, HCC3, with a Ka of 2 x 10(7) l/mol, increased the inhibition of papain by cystatin C and was suitable for use in immunoblotting, immunohistochemistry and in the construction of a sensitive sandwich enzyme immunoassay for quantification of cystatin C. It recognized not only free cystatin C but also cystatin C in complexes with cysteine proteinases. The kininogen antibody, HK4, was directed against the third, cysteine proteinase inhibitory domain of the heavy chain of kininogen (Ka = 1 X 10(7) l/mol), but did not influence the papain inhibitory activity of kininogen. It reacted with free kininogen as well as kininogen in complex with cysteine proteinases. Both antibodies could be used for the production of specific immunosorbents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064278     DOI: 10.3109/00365518809085775

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  16 in total

Review 1.  Commentary: clinical diagnostic use of cystatin C.

Authors:  Davis Massey
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.

Authors:  Hanna Wallin; Jenny Apelqvist; Freddi Andersson; Ulf Ekström; Magnus Abrahamson
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

3.  Fertility defects in mice expressing the L68Q variant of human cystatin C: a role for amyloid in male infertility.

Authors:  Sandra Whelly; Gaiane Serobian; Clinton Borchardt; Jonathan Powell; Seethal Johnson; Katarina Hakansson; Veronica Lindstrom; Magnus Abrahamson; Anders Grubb; Gail A Cornwall
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

4.  Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.

Authors:  C G Huh; K Håkansson; C M Nathanson; U P Thorgeirsson; N Jonsson; A Grubb; M Abrahamson; S Karlsson
Journal:  Mol Pathol       Date:  1999-12

5.  Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.

Authors:  H H Heidtmann; U Salge; M Abrahamson; M Bencina; L Kastelic; N Kopitar-Jerala; V Turk; T T Lah
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

6.  Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes.

Authors:  Hanna Wallin; Magnus Abrahamson; Ulf Ekström
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

7.  Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells.

Authors:  M Bjarnadottir; B S Wulff; M Sameni; B F Sloane; D Keppler; A Grubb; M Abrahamson
Journal:  Mol Pathol       Date:  1998-12

8.  Increased body temperature accelerates aggregation of the Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy.

Authors:  M Abrahamson; A Grubb
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Cystatin C in the human pancreas and gut: an immunohistochemical study of normal and neoplastic tissues.

Authors:  H Lignelid; B Jacobsson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Authors:  Jon J Briggs; Mads H Haugen; Harald T Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.